Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04864951
Other study ID # 1186/2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2, 2021
Est. completion date November 1, 2021

Study information

Verified date March 2023
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orientation, which is adapted from the largest published study.


Description:

All transpeople who visit the outpatient clinic are asked to participate in the study. After being informed and signing the Informed Consent Form, the subjects are asked to give first-void urine and fill out the survey. The urine samples are sent pseudonymously to the University of Ljubljana for analysis. The subjects will be informed about their results within 3 weeks.If the result is positive, the subjects will be offered voluntary further care in our HPV outpatient clinic. However, this will take place outside the study. The data collected there can be used for further analyses.


Recruitment information / eligibility

Status Completed
Enrollment 203
Est. completion date November 1, 2021
Est. primary completion date November 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Transpeople - Age over 18 years - Sufficient knowledge of German Exclusion Criteria: - Age under 18 years - Insufficient knowledge of German

Study Design


Intervention

Diagnostic Test:
Colli-Pee urine collection device
first-void urine is collected using Colli-Pee and subsequently analyzed using Anyplex™ II HPV HR Detection from Seegene.
Other:
Survey
Subjects are asked to complete a survey that includes questions about sexual orientation, hormone therapy, gender reassignment surgery, number of sexual partners, HPV vaccination, and smoking

Locations

Country Name City State
Austria Medical University of Vienna Vienna
Slovenia Institute of Microbiology and Immunology Faculty of Medicine Ljubljana

Sponsors (1)

Lead Sponsor Collaborator
Sophie Pils

Countries where clinical trial is conducted

Austria,  Slovenia, 

References & Publications (1)

Reisner SL, Deutsch MB, Peitzmeier SM, White Hughto JM, Cavanaugh TP, Pardee DJ, McLean SA, Panther LA, Gelman M, Mimiaga MJ, Potter JE. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One. 2018 Mar 14;13(3):e0190172. doi: 10.1371/journal.pone.0190172. eCollection 2018. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary HPV prevalence in transpeople HPV prevalence in transpeople one year
See also
  Status Clinical Trial Phase
Recruiting NCT05487794 - Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis N/A
Completed NCT02185274 - Observational Study on Metabolism and Psychopathology in Transsexual Patients
Recruiting NCT04838249 - Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Completed NCT00146146 - Testosterone and Its Metabolites in GID Phase 3
Completed NCT04290286 - i2TransHealth: Interdisciplinary, Internet-based Trans Health Care N/A
Completed NCT00435513 - A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism Phase 0
Recruiting NCT03637920 - Sexuality in Transmen During Hormone and Operative Treatment
Completed NCT03823014 - Use of an External Erectile Device in Transgender Man Following Phalloplasty N/A
Recruiting NCT03872648 - TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
Completed NCT01065220 - Sex Steroids and the Serotonin Transporter Phase 4
Enrolling by invitation NCT03595956 - Transgender Cohort Study of Gender Affirmation and HIV-related Health
Completed NCT02119377 - First Australian National Trans Mental Health Study N/A
Completed NCT02518009 - GEnder Dysphoria Treatment in Sweden
Completed NCT00135148 - Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group N/A